Hypertensive nephropathy classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypertensive nephropathy}} | {{Hypertensive nephropathy}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}} {{AE}} {{AN}} | {{CMG}} {{AE}} {{AN}} | ||
==Classification== | ==Classification== | ||
Line 19: | Line 21: | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
[[Category:Needs content]] |
Revision as of 21:00, 28 February 2013
Hypertensive nephropathy Microchapters |
Differentiating Hypertensive Nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hypertensive nephropathy classification On the Web |
American Roentgen Ray Society Images of Hypertensive nephropathy classification |
Risk calculators and risk factors for Hypertensive nephropathy classification |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Classification
Hypertensive nephropathy is divided into two distinct entities:
- Benign arteriolar nephrosclerosis
- Seen in patients who are hypertensive for a long period of time (> 150/90 mm Hg) but has not progressed to malignant stage.
- Malignant (accelerated) arteriolar nephrosclerosis
- Characterized by sudden elevation of blood pressure (diastolic pressure > 130 mm Hg) along with papilledema, central nervous system manifestations like confusion, cardiac decompensation and acute progressive decline in renal function.